A novel prognostic marker for cardiovascular risk in individuals with type 2 diabetes (T2D) has been identified by the IMMEDIAB team – Immunity and Metabolism of Diabetes, led by Nicolas Venteclef at INEM - Institut Necker Enfants Malades.
On January 26, 2024, Lida Katsimpardi received the 2023 Prix Desmarest by the Pierre Deniker Foundation. Lida’s research in the field of cognitive decline, depression and Alzheimer's disease, and her dedication to deciphering underlying mechanisms and finding new therapies, have earned her this prestigious recognition.
Every year, the Pierre Deniker Foundation awards grants and prizes to research teams to advance knowledge on mental illnesses.